Fluconazole therapy for treatment of invasive candidiasis in Intensive Care patients. Is it still valid from a pharmacological point of view?
Fluconazole - antimycotic belonging to the first generation azoles - is widely used as treatment for invasive candidiasis and candidemia in numerous clinical settings as Neonatal Intensive Care Unit (NICU) and adult Intensive Care Unit (ICU), as well as oncology, onco-hematology and solid organ tran...
Saved in:
Main Authors: | Mario Musu (Author), Maurizio Evangelista (Author), Paolo Mura (Author), Andrea Cossu (Author), Massimiliano Carta (Author), Gian Nicola Aru (Author), Gabriele Finco (Author) |
---|---|
Format: | Book |
Published: |
Hygeia Press di Corridori Marinella,
2014-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fluconazole prophylaxis for prevention of invasive candidiasis in extremely preterm infants
by: Chun Soo Kim
Published: (2021) -
Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
by: Gebremedhin Beedemariam Gebretekle, et al.
Published: (2022) -
Efficacy of Fluconazole Prophylaxis on Invasive Candidiasis Infection in Extremely Low Birth Weight Neonates
by: Hosein Dalili, et al.
Published: (2020) -
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
by: Grau S, et al.
Published: (2015) -
General anesthesia and neurotoxicity on the developing brain
by: Gabriele Finco, et al.
Published: (2018)